<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02610036</url>
  </required_header>
  <id_info>
    <org_study_id>PROT 18 /2011Cardiovascular</org_study_id>
    <nct_id>NCT02610036</nct_id>
  </id_info>
  <brief_title>Obliterating Diabetic Microangiopathy of the Diabetic Foot</brief_title>
  <official_title>Pilot Study on the Presence of Microangiopathy in Diabetic Foot Ulcer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Multimedica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Multimedica</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study will be the assessment of microangiopathy determined by the
      increase of capillary basement membrane thickness and decrease of capillary lumen area in the
      foot ulcer of 30 neuropathic and 30 neuroischemic type 2 diabetic patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary endpoint of the study is to quantitatively evaluate the presence of microangiopathy
      as increase of capillary basement membrane thickness and decrease of capillary lumen area
      determined by transmission electron microscopy analysis in type 2 diabetic patients with only
      motor-sensory neuropathy or chronic critical ischemia affected by foot ulcer.

      The following parameters will be evaluated:

        -  presence of capillary (n/mm2) and thrombosis (%) and correlation of this quantitative
           histological data with ischemic parameters (TcPO2, ankle-brachial index) and risk of
           diastasis

        -  correlation between presence of inflammatory infiltrate (leukocytes/mm2) with blood
           inflammatory parameters (erythrocyte sedimentation rate (ESR), C-reactive protein,
           alpha-2 globulin)

        -  rate of diastasis and/or time required for recovery associated with histopathological
           data

        -  presence of acanthosis related to clinical and demographic variables
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>presence of microangiopathy</measure>
    <time_frame>24 hours after surgical amputation at the first ray level for treatment of foot ulcer</time_frame>
    <description>presence of microangiopathy as increase of capillary basement membrane thickness and decrease of capillary lumen area by transmission electron microscopy in the skin of type 2 diabetic patients with foot ulcer</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Diabetic Foot</condition>
  <arm_group>
    <arm_group_label>neuropathic type 2 diabetic patients</arm_group_label>
    <description>the foot ulcer of 30 neuropathic and 30 neuroischemic type 2 diabetic patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>neuroischemic type 2 diabetic patients</arm_group_label>
    <description>the foot ulcer of 30 neuropathic and 30 neuroischemic type 2 diabetic patients</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        30 diabetic patients with only neuropathy, 30 diabetic patients with critical limb ischemia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:-

          -  adult type 2 diabetic patients of either gender

          -  diabetes for more than 10 years

          -  motor-sensory diabetic neuropathy with or without chronic critical ischemia

          -  local residents

          -  ulcer with surgical therapy indication of removal the 1st ray because of gangrene or
             osteomyelitis

        Exclusion Criteria:

          -  type 1 diabetic patients

          -  diabetes for less than 10 years

          -  renal replacement therapy

          -  urgent surgical procedure for sepsis

          -  immunosuppressive therapy

          -  not local residents

               -  Cancer with adverse prognosis in months, or chemotheraputic treatment

               -  Ongoing or planned pregnancy

               -  Lack of consent to participate to the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ezio Faglia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Multimedica</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diabetic Foot Center - IRCCS Multimedica,</name>
      <address>
        <city>Sesto San Giovanni</city>
        <state>(Milan), Italy</state>
        <zip>20099</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2012</study_first_submitted>
  <study_first_submitted_qc>November 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2015</study_first_posted>
  <last_update_submitted>November 19, 2015</last_update_submitted>
  <last_update_submitted_qc>November 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>foot ulcer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

